{
  "source": "Google Sheets 資料區 (gid=1738940485)",
  "generated_note": "Auto-generated by convert_spreadsheet.py. Do not edit manually.",
  "drug_count": 50,
  "regimen_count": 81,
  "drugs": [
    {
      "name": "Oxacillin",
      "category_raw": "Penicillins",
      "generation": null,
      "coverage": {
        "Strep": "v",
        "MSSA": "v"
      },
      "penetration": {
        "BBB": true
      },
      "regimens": [
        {
          "route": "IV",
          "indication": null,
          "dosages": {
            "<5": "2g Q4H",
            "5~10": "2g Q4H",
            "10~15": "2g Q4H",
            "15~20": "2g Q4H",
            "20~25": "2g Q4H",
            "25~30": "2g Q4H",
            "30~40": "2g Q4H",
            "40~50": "2g Q4H",
            "50~60": "2g Q4H",
            "60~80": "2g Q4H",
            "80~90": "2g Q4H",
            "Normal": "2g Q4H"
          },
          "hd": "No data",
          "crrt": "No data"
        }
      ],
      "notes": null,
      "toxicities": null
    },
    {
      "name": "Ampicillin",
      "category_raw": "Penicillins",
      "generation": null,
      "coverage": {
        "Strep": "v",
        "Efc": "v",
        "Efm": "v",
        "Anae": "++"
      },
      "penetration": {
        "BBB": true
      },
      "regimens": [
        {
          "route": "IV/PO",
          "indication": null,
          "dosages": {
            "<5": "No data",
            "5~10": "No data",
            "10~15": "1~2g Q8H~Q12H",
            "15~20": "1~2g Q8H~Q12H",
            "20~25": "1~2g Q8H~Q12H",
            "25~30": "1~2g Q8H~Q12H",
            "30~40": "1~2g Q6H~Q8H",
            "40~50": "1~2g Q6H~Q8H",
            "50~60": "1~2g Q4H~Q6H",
            "60~80": "1~2g Q4H~Q6H",
            "80~90": "1~2g Q4H~Q6H",
            "Normal": "1~2g IV Q4H~Q6H; 250~500mg PO Q6H"
          },
          "hd": "1~2g Q12H; one of the dialysis day doses AD",
          "crrt": "1~2g Q8H~Q12H"
        }
      ],
      "notes": "Can used for Listeria meningitis",
      "toxicities": null
    },
    {
      "name": "Unasyn = Amsulber (Ampicillin + Sulbactam)",
      "category_raw": "Penicillins",
      "generation": null,
      "coverage": {
        "Strep": "v",
        "MSSA": "v",
        "Efc": "v",
        "Efm": "v",
        "Anae": "++",
        "MDRAB": "v"
      },
      "penetration": {
        "BBB": true
      },
      "regimens": [
        {
          "route": "IV",
          "indication": null,
          "dosages": {
            "<5": "No data",
            "5~10": "1.5~3g QD",
            "10~15": "1.5~3g QD",
            "15~20": "1.5~3g Q12H",
            "20~25": "1.5~3g Q12H",
            "25~30": "1.5~3g Q12H",
            "30~40": "1.5~3g Q6H",
            "40~50": "1.5~3g Q6H",
            "50~60": "1.5~3g Q6H",
            "60~80": "1.5~3g Q6H",
            "80~90": "1.5~3g Q6H",
            "Normal": "3g Q6H; > 30 min"
          },
          "hd": "1.5~3g QD, AD",
          "crrt": "1.5~3g Q8H~Q12H, AD"
        },
        {
          "route": "IV",
          "indication": "High dose for combined treatment of CRAB",
          "dosages": {
            "<5": "6g Q12H",
            "5~10": "6g Q12H",
            "10~15": "6g Q12H",
            "15~20": "6g Q12H",
            "20~25": "6g Q8H",
            "25~30": "6g Q8H",
            "30~40": "6g Q8H",
            "40~50": "6g Q8H",
            "50~60": "9g Q8H",
            "60~80": "9g Q8H",
            "80~90": "9g Q8H",
            "Normal": "9g Q8H"
          },
          "hd": "6g Q12H",
          "crrt": null
        }
      ],
      "notes": "Combination therapy of VAP: 9g > 4hrs and repeat Q8H",
      "toxicities": null
    },
    {
      "name": "Amox-Clav/Curam/Augmentin",
      "category_raw": "Penicillins",
      "generation": null,
      "coverage": {
        "Strep": "v"
      },
      "penetration": {
        "BBB": true
      },
      "regimens": [
        {
          "route": "PO",
          "indication": "500/125",
          "dosages": {
            "<5": "250~500mg Amox QD",
            "5~10": "250~500mg Amox QD",
            "10~15": "250~500mg Amox Q12H",
            "15~20": "250~500mg Amox Q12H",
            "20~25": "250~500mg Amox Q12H",
            "25~30": "250~500mg Amox Q12H",
            "30~40": "500/125mg Q8H",
            "40~50": "500/125mg Q8H",
            "50~60": "500/125mg Q8H",
            "60~80": "500/125mg Q8H",
            "80~90": "500/125mg Q8H",
            "Normal": "500/125mg Q8H"
          },
          "hd": "250~500mg Amox QD; extra dose AD",
          "crrt": "No data"
        },
        {
          "route": "PO",
          "indication": "875/125",
          "dosages": {
            "<5": "250~500mg Amox QD",
            "5~10": "250~500mg Amox QD",
            "10~15": "250~500mg Amox Q12H",
            "15~20": "250~500mg Amox Q12H",
            "20~25": "250~500mg Amox Q12H",
            "25~30": "250~500mg Amox Q12H",
            "30~40": "875/125mg Q12H",
            "40~50": "875/125mg Q12H",
            "50~60": "875/125mg Q12H",
            "60~80": "875/125mg Q12H",
            "80~90": "875/125mg Q12H",
            "Normal": "875/125mg Q12H"
          },
          "hd": "250~500mg Amox QD; extra dose AD",
          "crrt": "No data"
        },
        {
          "route": "IV",
          "indication": "1000/200",
          "dosages": {
            "<5": "1000/200mg x1, then 500/100mg QD",
            "5~10": "1000/200mg x1, then 500/100mg QD",
            "10~15": "1000/200mg x1, then 500/100mg Q12H",
            "15~20": "1000/200mg x1, then 500/100mg Q12H",
            "20~25": "1000/200mg x1, then 500/100mg Q12H",
            "25~30": "1000/200mg x1, then 500/100mg Q12H",
            "30~40": "1000/200mg Q8H",
            "40~50": "1000/200mg Q8H",
            "50~60": "1000/200mg Q8H",
            "60~80": "1000/200mg Q8H",
            "80~90": "1000/200mg Q8H",
            "Normal": "1000/200mg Q8H"
          },
          "hd": "1000/200mg x1, then 500/100mg QD (+ extra dose AD)",
          "crrt": "No data"
        }
      ],
      "notes": null,
      "toxicities": {
        "hepatic": "Hepatotoxicity",
        "gi": "nausea/vomiting, diarrhea",
        "skin": "Rash (with EBV)",
        "hematologic": "neutropenia, eosinophilia, thrombocytopenia"
      }
    },
    {
      "name": "Tazocin (Piperacillin + Tazobactam)",
      "category_raw": "Penicillins",
      "generation": null,
      "coverage": {
        "Strep": "v",
        "MSSA": "v",
        "Efc": "v",
        "Efm": "v",
        "PsA": "+",
        "Anae": "++"
      },
      "penetration": {
        "BBB": true
      },
      "regimens": [
        {
          "route": "IV",
          "indication": null,
          "dosages": {
            "<5": "2.25g Q8H",
            "5~10": "2.25g Q8H",
            "10~15": "2.25g Q8H",
            "15~20": "2.25g Q8H",
            "20~25": "2.25g Q6H",
            "25~30": "2.25g Q6H",
            "30~40": "2.25g Q6H",
            "40~50": "3.375g Q6H",
            "50~60": "3.375g Q6H",
            "60~80": "3.375g Q6H",
            "80~90": "3.375g Q6H",
            "Normal": "3.375g Q6H"
          },
          "hd": "2.25g Q12H; Extra 0.75g AD",
          "crrt": "3.375g~4.5g Q6H"
        },
        {
          "route": "IV",
          "indication": "Nosocomial pneumonia",
          "dosages": {
            "<5": "2.25g Q6H",
            "5~10": "2.25g Q6H",
            "10~15": "2.25g Q6H",
            "15~20": "2.25g Q6H",
            "20~25": "3.375g Q6H",
            "25~30": "3.375g Q6H",
            "30~40": "3.375g Q6H",
            "40~50": "4.5g Q6H",
            "50~60": "4.5g Q6H",
            "60~80": "4.5g Q6H",
            "80~90": "4.5g Q6H",
            "Normal": "4.5g Q6H"
          },
          "hd": "2.25g Q8H; Extra 0.75g AD",
          "crrt": "3.375g~4.5g Q6H"
        },
        {
          "route": "IV",
          "indication": "Extended infusion",
          "dosages": {
            "<5": "4.5g Q12H (>4hrs)",
            "5~10": "4.5g Q12H (>4hrs)",
            "10~15": "4.5g Q12H (>4hrs)",
            "15~20": "4.5g Q12H (>4hrs)",
            "20~25": "4.5g Q8H (>4hrs)",
            "25~30": "4.5g Q8H (>4hrs)",
            "30~40": "4.5g Q8H (>4hrs)",
            "40~50": "4.5g Q8H (>4hrs)",
            "50~60": "4.5g Q8H (>4hrs)",
            "60~80": "4.5g Q8H (>4hrs)",
            "80~90": "4.5g Q8H (>4hrs)",
            "Normal": "4.5g Q8H (>4hrs)"
          },
          "hd": "4.5g Q12H (>4hrs)",
          "crrt": "3.375g~4.5g Q8H (>4hrs)"
        }
      ],
      "notes": null,
      "toxicities": null
    },
    {
      "name": "Cefuroxime (2°)",
      "category_raw": "Cephalosporins",
      "generation": "2°",
      "coverage": {
        "Strep": "v",
        "MSSA": "v"
      },
      "penetration": null,
      "regimens": [
        {
          "route": "IV",
          "indication": null,
          "dosages": null,
          "hd": null,
          "crrt": null
        }
      ],
      "notes": null,
      "toxicities": null
    },
    {
      "name": "Cefoxitin (2°)",
      "category_raw": "Cephalosporins",
      "generation": "2°",
      "coverage": {
        "Strep": "v",
        "MSSA": "v"
      },
      "penetration": null,
      "regimens": [
        {
          "route": "IV",
          "indication": null,
          "dosages": {
            "<5": "2g QD~QOD",
            "5~10": "2g QD~QOD",
            "10~15": "2g Q8H~Q12H",
            "15~20": "2g Q8H~Q12H",
            "20~25": "2g Q8H~Q12H",
            "25~30": "2g Q8H~Q12H",
            "30~40": "2g Q8H~Q12H",
            "40~50": "2g Q8H~Q12H",
            "50~60": "2g Q8H",
            "60~80": "2g Q8H",
            "80~90": "2g Q8H",
            "Normal": "2g Q8H"
          },
          "hd": "2g QD~QOD (+ extra 1g AD)",
          "crrt": null
        }
      ],
      "notes": null,
      "toxicities": {
        "skin": "Local phlebitis (rare)",
        "hematologic": "neutropenia, eosinophilia, increased PT/PTT"
      }
    },
    {
      "name": "Cefmetazole (2°)",
      "category_raw": "Cephalosporins",
      "generation": "2°",
      "coverage": {
        "Strep": "v",
        "MSSA": "v",
        "Anae": "+"
      },
      "penetration": null,
      "regimens": [
        {
          "route": "IV",
          "indication": null,
          "dosages": {
            "<5": "1~2g QOD",
            "5~10": "1~2g QOD",
            "10~15": "1~2g QD",
            "15~20": "1~2g QD",
            "20~25": "1~2g QD",
            "25~30": "1~2g QD",
            "30~40": "1g Q12H",
            "40~50": "1g Q12H",
            "50~60": "1~2g Q12H",
            "60~80": "1~2g Q12H",
            "80~90": "1~2g Q12H",
            "Normal": "2g Q6H~Q8H~Q12H"
          },
          "hd": "1~2g QOD; AD",
          "crrt": null
        }
      ],
      "notes": "需補充 Vit K1",
      "toxicities": {
        "gi": "nausea/vomiting, diarrhea",
        "hematologic": "Coagulopathy"
      }
    },
    {
      "name": "Cefixime (3°)",
      "category_raw": "Cephalosporins",
      "generation": "3°",
      "coverage": null,
      "penetration": null,
      "regimens": [
        {
          "route": "PO",
          "indication": null,
          "dosages": {
            "<5": "200mg QD",
            "5~10": "200mg QD",
            "10~15": "200mg QD",
            "15~20": "200mg QD",
            "20~25": "300mg QD",
            "25~30": "300mg QD",
            "30~40": "300mg QD",
            "40~50": "300mg QD",
            "50~60": "300mg QD",
            "60~80": "400mg QD or 200mg BID",
            "80~90": "400mg QD or 200mg BID",
            "Normal": "400mg QD or 200mg BID"
          },
          "hd": null,
          "crrt": null
        }
      ],
      "notes": null,
      "toxicities": null
    },
    {
      "name": "Ceftriaxone (3°)",
      "category_raw": "Cephalosporins",
      "generation": "3°",
      "coverage": {
        "Strep": "v",
        "MSSA": "v",
        "Efc": "v"
      },
      "penetration": {
        "BBB": true,
        "Pros": true,
        "Endo": true
      },
      "regimens": [
        {
          "route": "IV",
          "indication": null,
          "dosages": {
            "<5": "1~2g Q12H~QD",
            "5~10": "1~2g Q12H~QD",
            "10~15": "1~2g Q12H~QD",
            "15~20": "1~2g Q12H~QD",
            "20~25": "1~2g Q12H~QD",
            "25~30": "1~2g Q12H~QD",
            "30~40": "1~2g Q12H~QD",
            "40~50": "1~2g Q12H~QD",
            "50~60": "1~2g Q12H~QD",
            "60~80": "1~2g Q12H~QD",
            "80~90": "1~2g Q12H~QD",
            "Normal": "1~2g Q12H~QD"
          },
          "hd": "1~2g Q12H~QD",
          "crrt": null
        }
      ],
      "notes": null,
      "toxicities": null
    },
    {
      "name": "Ceftazidime (3°)",
      "category_raw": "Cephalosporins",
      "generation": "3°",
      "coverage": {
        "PsA": "+"
      },
      "penetration": {
        "BBB": true,
        "Pros": true,
        "Endo": true
      },
      "regimens": [
        {
          "route": "IV",
          "indication": null,
          "dosages": {
            "<5": "1~2g QD",
            "5~10": "1~2g QD",
            "10~15": "1~2g Q12H~QD",
            "15~20": "1~2g Q12H~QD",
            "20~25": "1~2g Q12H~QD",
            "25~30": "1~2g Q12H~QD",
            "30~40": "1~2g Q12H~QD",
            "40~50": "1~2g Q12H~QD",
            "50~60": "1~2g Q8H~Q12H",
            "60~80": "1~2g Q8H~Q12H",
            "80~90": "1~2g Q8H~Q12H",
            "Normal": "1~2g Q8H~Q12H"
          },
          "hd": "0.5~1.0g QD; AD",
          "crrt": null
        }
      ],
      "notes": "不能用於GPC",
      "toxicities": null
    },
    {
      "name": "Flomoxef (Flumarin)",
      "category_raw": "Cephalosporins",
      "generation": null,
      "coverage": {
        "Strep": "v",
        "MSSA": "v",
        "Anae": "++"
      },
      "penetration": null,
      "regimens": [
        {
          "route": "IV",
          "indication": null,
          "dosages": {
            "<5": "0.5g QD",
            "5~10": "1g QD",
            "10~15": "1g QD",
            "15~20": "1g QD",
            "20~25": "1g QD",
            "25~30": "1g Q12H",
            "30~40": "1g Q12H",
            "40~50": "1g Q12H",
            "50~60": "1g Q8H",
            "60~80": "1g Q8H",
            "80~90": "1g Q8H",
            "Normal": "1g Q6H~Q12H"
          },
          "hd": "H/D 前、後 1g",
          "crrt": null
        }
      ],
      "notes": "需補充 Vit K1",
      "toxicities": null
    },
    {
      "name": "Brosym (cefoperazone + sulbactam)(3°)",
      "category_raw": "Cephalosporins",
      "generation": "3°",
      "coverage": {
        "Strep": "v",
        "MSSA": "v",
        "PsA": "+",
        "Anae": "+",
        "MDRAB": "v"
      },
      "penetration": null,
      "regimens": [
        {
          "route": "IV",
          "indication": null,
          "dosages": {
            "<5": "0.5g Sulbactam Q12H",
            "5~10": "0.5g Sulbactam Q12H",
            "10~15": "0.5g Sulbactam Q12H",
            "15~20": "1g Sulbactam Q12H",
            "20~25": "1g Sulbactam Q12H",
            "25~30": "1g Sulbactam Q12H",
            "30~40": "1~2g Cefoperazone Q12H",
            "40~50": "1~2g Cefoperazone Q12H",
            "50~60": "1~2g Cefoperazone Q12H",
            "60~80": "1~2g Cefoperazone Q12H",
            "80~90": "1~2g Cefoperazone Q12H",
            "Normal": "1~2g Cefoperazone Q12H"
          },
          "hd": "0.5g Sulbactam Q12H, AD on dialysis day",
          "crrt": "1g Sulbactam Q8H"
        }
      ],
      "notes": "需補充 Vit K1",
      "toxicities": null
    },
    {
      "name": "Cefepime (4°)",
      "category_raw": "Cephalosporins",
      "generation": "4°",
      "coverage": {
        "Strep": "v",
        "MSSA": "v",
        "PsA": "++"
      },
      "penetration": {
        "BBB": true
      },
      "regimens": [
        {
          "route": "IV",
          "indication": null,
          "dosages": {
            "<5": "1g QD",
            "5~10": "1g QD",
            "10~15": "2g QD",
            "15~20": "2g QD",
            "20~25": "2g QD",
            "25~30": "2g QD",
            "30~40": "2g Q12H",
            "40~50": "2g Q12H",
            "50~60": "2g Q12H",
            "60~80": "2g Q8H",
            "80~90": "2g Q8H",
            "Normal": "2g Q8H"
          },
          "hd": "1g QD, AD",
          "crrt": "2g Q12H~QD"
        }
      ],
      "notes": null,
      "toxicities": null
    },
    {
      "name": "Zavicefta (Ceftazidime + Avibactam)",
      "category_raw": "Cephalosporins",
      "generation": null,
      "coverage": {
        "CRKP": "v"
      },
      "penetration": null,
      "regimens": [
        {
          "route": "IV",
          "indication": null,
          "dosages": {
            "<5": "0.94g QOD, drip > 2hrs",
            "5~10": "0.94g QD, drip > 2hrs",
            "10~15": "0.94g QD, drip > 2hrs",
            "15~20": "0.94g Q12H, drip > 2hrs",
            "20~25": "0.94g Q12H, drip > 2hrs",
            "25~30": "0.94g Q12H, drip > 2hrs",
            "30~40": "1.25g Q8H, drip > 2hrs",
            "40~50": "1.25g Q8H, drip > 2hrs",
            "50~60": "2.5g Q8H, drip > 2hrs",
            "60~80": "2.5g Q8H, drip > 2hrs",
            "80~90": "2.5g Q8H, drip > 2hrs",
            "Normal": "2.5g Q8H, drip > 2hrs"
          },
          "hd": "As CrCl <= 15; AD",
          "crrt": null
        }
      ],
      "notes": null,
      "toxicities": {
        "neurologic": "seizures, coma",
        "gi": "nausea, vomiting (when with Metronidazole)"
      }
    },
    {
      "name": "Ceftobiprole (5°)",
      "category_raw": "Cephalosporins",
      "generation": "5°",
      "coverage": {
        "Strep": "v",
        "MSSA": "v",
        "PsA": "++",
        "MRSA": "+"
      },
      "penetration": null,
      "regimens": [
        {
          "route": "IV",
          "indication": null,
          "dosages": null,
          "hd": null,
          "crrt": null
        }
      ],
      "notes": null,
      "toxicities": null
    },
    {
      "name": "Cefiderocol",
      "category_raw": "Cephalosporins",
      "generation": null,
      "coverage": null,
      "penetration": null,
      "regimens": [
        {
          "route": "IV",
          "indication": null,
          "dosages": null,
          "hd": null,
          "crrt": null
        }
      ],
      "notes": "注入 10 mL 0.9% 生理食鹽水於 vial 中，並輕輕振搖使之溶解成 11.2 ml 的溶液，靜置直到表面泡沫消失 (通常於 2 分鐘內)，並從已配製完成的小瓶 (vial) 中抽 [] ml的溶液，並將其注入一內含 100 mL 的 0.9% 生理食鹽水袋中，完成製備",
      "toxicities": null
    },
    {
      "name": "Ertapenem",
      "category_raw": "Carbapenems",
      "generation": null,
      "coverage": {
        "Strep": "v",
        "MSSA": "v",
        "Efc": "v",
        "Anae": "++",
        "ESBL": "v",
        "MDRAB": "v"
      },
      "penetration": null,
      "regimens": [
        {
          "route": "IV/IM",
          "indication": null,
          "dosages": {
            "<5": "500mg QD",
            "5~10": "500mg QD",
            "10~15": "500mg QD",
            "15~20": "500mg QD",
            "20~25": "500mg QD",
            "25~30": "500mg QD",
            "30~40": "1g QD",
            "40~50": "1g QD",
            "50~60": "1g QD",
            "60~80": "1g QD",
            "80~90": "1g QD",
            "Normal": "1g QD"
          },
          "hd": "500mg QD (150 mg AD if given ≤6 hr bef HD) OR 500 mg 3x/wk AD",
          "crrt": "500mg~1g QD"
        }
      ],
      "notes": "會降低valproate血中濃度甚至導致癲癇發作;\n不能打 PsA; \nLidocaine diluent for IM, careful of lidocaine allergy",
      "toxicities": {
        "general": "headache",
        "hepatic": "increased LFTs",
        "neurologic": "Seizure (very low)",
        "gi": "nausea/vomiting, diarrhea",
        "skin": "Local phlebitis, drug rash",
        "hematologic": "neutropenia, eosinophilia"
      }
    },
    {
      "name": "Culin (Imipenem + Cilastatin)",
      "category_raw": "Carbapenems",
      "generation": null,
      "coverage": {
        "Strep": "v",
        "MSSA": "v",
        "Efc": "v",
        "PsA": "+",
        "Anae": "++",
        "ESBL": "v",
        "MDRAB": "v"
      },
      "penetration": {
        "BBB": true
      },
      "regimens": [
        {
          "route": "IV",
          "indication": null,
          "dosages": {
            "<5": "No data",
            "5~10": "No data",
            "10~15": "No data",
            "15~20": "200mg Q6H or 500mg Q12H",
            "20~25": "200mg Q6H or 500mg Q12H",
            "25~30": "200mg Q6H or 500mg Q12H",
            "30~40": "300mg Q6H or 500mg Q8H",
            "40~50": "300mg Q6H or 500mg Q8H",
            "50~60": "400~500mg Q6H",
            "60~80": "400~500mg Q6H",
            "80~90": "400~500mg Q6H",
            "Normal": "500mg Q6H or 1g Q8H"
          },
          "hd": "200mg Q6H or 500mg Q12H; AD",
          "crrt": "500mg~1g Q12H"
        },
        {
          "route": "IV",
          "indication": "I susceptibility",
          "dosages": {
            "<5": "No data",
            "5~10": "No data",
            "10~15": "No data",
            "15~20": "500mg Q12H",
            "20~25": "500mg Q12H",
            "25~30": "500mg Q12H",
            "30~40": "500mg Q6H",
            "40~50": "500mg Q6H",
            "50~60": "750mg Q8H",
            "60~80": "750mg Q8H",
            "80~90": "750mg Q8H",
            "Normal": "1g Q6H"
          },
          "hd": "500mg Q12H; AD",
          "crrt": "500mg~1g Q12H"
        }
      ],
      "notes": "會降低valproate血中濃度甚至導致癲癇發作;\nMeropenem susceptibility should not be relied upon as a surrogate to predict susceptibility to Imipenem",
      "toxicities": {
        "neurologic": "Seizure (higher than Meropenem)",
        "gi": "nausea/vomiting, diarrhea",
        "skin": "Local phlebitis",
        "hematologic": "neutropenia, eosinophilia, thrombocytopenia"
      }
    },
    {
      "name": "Meropenem",
      "category_raw": "Carbapenems",
      "generation": null,
      "coverage": {
        "Strep": "v",
        "MSSA": "v",
        "Efc": "v",
        "PsA": "+",
        "Anae": "++",
        "ESBL": "v",
        "MDRAB": "v"
      },
      "penetration": {
        "BBB": true
      },
      "regimens": [
        {
          "route": "IV",
          "indication": null,
          "dosages": {
            "<5": "0.5g QD",
            "5~10": "0.5g QD",
            "10~15": "0.5g Q12H",
            "15~20": "0.5g Q12H",
            "20~25": "0.5g Q12H",
            "25~30": "1g Q12H",
            "30~40": "1g Q12H",
            "40~50": "1g Q12H",
            "50~60": "1g Q8H",
            "60~80": "1g Q8H",
            "80~90": "1g Q8H",
            "Normal": "1g Q8H"
          },
          "hd": "0.5g QD; AD",
          "crrt": "750mg Q8H"
        },
        {
          "route": "IV",
          "indication": "Prolonged infusion dose",
          "dosages": {
            "<5": "No data",
            "5~10": "No data",
            "10~15": "1g Q12H, drip > 3 hours [熱病dose，感染科不建議]",
            "15~20": "1g Q12H, drip > 3 hours [熱病dose，感染科不建議]",
            "20~25": "1g Q12H, drip > 3 hours [熱病dose，感染科不建議]",
            "25~30": "1g Q12H, drip > 3 hours [熱病dose，感染科不建議]",
            "30~40": "1g Q8H, drip > 3 hours [熱病dose，感染科不建議]",
            "40~50": "1g Q8H, drip > 3 hours [熱病dose，感染科不建議]",
            "50~60": "2g Q8H, drip > 3 hours [熱病dose，感染科不建議]",
            "60~80": "2g Q8H, drip > 3 hours [熱病dose，感染科不建議]",
            "80~90": "2g Q8H, drip > 3 hours [熱病dose，感染科不建議]",
            "Normal": "2g Q8H, drip > 3 hours [熱病dose，感染科不建議]"
          },
          "hd": "No data",
          "crrt": "No data"
        }
      ],
      "notes": "會降低valproate血中濃度甚至導致癲癇發作; Prolonged infusion > 3hrs 可以降低死亡率，雖然熱病建議 Prolonged infusion 時給予的劑量較高，但本院感染科並不建議如此使用",
      "toxicities": {
        "neurologic": "Seizure (lower than Imipenem)"
      }
    },
    {
      "name": "Doripenem",
      "category_raw": "Carbapenems",
      "generation": null,
      "coverage": {
        "Strep": "v",
        "MSSA": "v",
        "Efc": "v",
        "PsA": "++",
        "Anae": "++",
        "ESBL": "v",
        "MDRAB": "v"
      },
      "penetration": null,
      "regimens": [
        {
          "route": "IV",
          "indication": null,
          "dosages": null,
          "hd": null,
          "crrt": null
        }
      ],
      "notes": "會降低valproate血中濃度甚至導致癲癇發作;",
      "toxicities": null
    },
    {
      "name": "Ciprofloxacin",
      "category_raw": "Fluoroquinolone",
      "generation": null,
      "coverage": {
        "MSSA": "v",
        "Efc": "v",
        "PsA": "+",
        "Atyp": "+"
      },
      "penetration": {
        "Pros": true
      },
      "regimens": [
        {
          "route": "PO",
          "indication": null,
          "dosages": {
            "<5": "No data",
            "5~10": "500~750mg QD",
            "10~15": "500~750mg QD",
            "15~20": "500~750mg QD",
            "20~25": "500~750mg QD",
            "25~30": "500~750mg QD",
            "30~40": "250~500mg Q12H",
            "40~50": "250~500mg Q12H",
            "50~60": "250~750mg Q12H",
            "60~80": "250~500mg Q12H",
            "80~90": "250~500mg Q12H",
            "Normal": "250~750mg Q12H"
          },
          "hd": "250~500mg QD; AD",
          "crrt": "250~500mg QD"
        },
        {
          "route": "PO",
          "indication": "XR)(Cystitis",
          "dosages": {
            "<5": "No data",
            "5~10": "500mg QD",
            "10~15": "500mg QD",
            "15~20": "500mg QD",
            "20~25": "500mg QD",
            "25~30": "500mg QD",
            "30~40": "500mg QD",
            "40~50": "500mg QD",
            "50~60": "500mg QD",
            "60~80": "500mg QD",
            "80~90": "500mg QD",
            "Normal": "500mg QD x3 days"
          },
          "hd": "500mg QD; AD",
          "crrt": "500mg QD"
        },
        {
          "route": "PO",
          "indication": "XR)(pyelonephritis/cUTI",
          "dosages": {
            "<5": "No data",
            "5~10": "500mg QD",
            "10~15": "1g QD",
            "15~20": "1g QD",
            "20~25": "1g QD",
            "25~30": "1g QD",
            "30~40": "1g QD",
            "40~50": "1g QD",
            "50~60": "1g QD",
            "60~80": "1g QD",
            "80~90": "1g QD",
            "Normal": "1g QD x7~14 days"
          },
          "hd": "500mg QD; AD",
          "crrt": "500mg QD"
        },
        {
          "route": "IV",
          "indication": null,
          "dosages": {
            "<5": "No data",
            "5~10": "200~400mg Q18H~QD",
            "10~15": "200~400mg Q18H~QD",
            "15~20": "200~400mg Q18H~QD",
            "20~25": "200~400mg Q18H~QD",
            "25~30": "200~400mg Q18H~QD",
            "30~40": "200~400mg Q8~12H",
            "40~50": "200~400mg Q8~12H",
            "50~60": "200~400mg Q8~12H",
            "60~80": "200~400mg Q8~12H",
            "80~90": "200~400mg Q8~12H",
            "Normal": "200~400mg Q8~12H"
          },
          "hd": "200~400mg QD; AD",
          "crrt": "200~400mg QD"
        }
      ],
      "notes": "注意 QTc prolonged",
      "toxicities": {
        "cardiac": "QTc prolonged",
        "neurologic": "exacerbate muscle weakness in MG",
        "hematologic": "Thrombocytopenia"
      }
    },
    {
      "name": "Levofloxacin",
      "category_raw": "Fluoroquinolone",
      "generation": null,
      "coverage": {
        "MSSA": "v",
        "Efc": "v",
        "Efm": "v",
        "Atyp": "++",
        "Steno": "v"
      },
      "penetration": {
        "Pros": true
      },
      "regimens": [
        {
          "route": "IV/PO",
          "indication": null,
          "dosages": {
            "<5": "750mg ST + 500mg QOD",
            "5~10": "750mg ST + 500mg QOD",
            "10~15": "750mg ST + 500mg QOD",
            "15~20": "750mg ST + 500mg QOD",
            "20~25": "750mg QOD",
            "25~30": "750mg QOD",
            "30~40": "750mg QOD",
            "40~50": "750mg QOD",
            "50~60": "750mg QD",
            "60~80": "750mg QD",
            "80~90": "750mg QD",
            "Normal": "750mg QD"
          },
          "hd": "750mg ST + 500mg QOD",
          "crrt": "750mg ST + 500mg QOD"
        }
      ],
      "notes": "注意 QTc prolonged",
      "toxicities": {
        "cardiac": "QTc prolonged",
        "endocrine": "Reversible adrenal insufficiency"
      }
    },
    {
      "name": "Moxifloxacin",
      "category_raw": "Fluoroquinolone",
      "generation": null,
      "coverage": {
        "Strep": "v",
        "MSSA": "v",
        "Efc": "v",
        "Efm": "v",
        "Anae": "+",
        "Atyp": "++"
      },
      "penetration": {
        "BBB": true,
        "Pros": true
      },
      "regimens": [
        {
          "route": "IV/PO",
          "indication": null,
          "dosages": {
            "<5": "400mg QD",
            "5~10": "400mg QD",
            "10~15": "400mg QD",
            "15~20": "400mg QD",
            "20~25": "400mg QD",
            "25~30": "400mg QD",
            "30~40": "400mg QD",
            "40~50": "400mg QD",
            "50~60": "400mg QD",
            "60~80": "400mg QD",
            "80~90": "400mg QD",
            "Normal": "400mg QD"
          },
          "hd": "400mg QD",
          "crrt": "400mg QD"
        }
      ],
      "notes": "注意 QTc prolonged; \nagainst respiratory and enteric pathogens",
      "toxicities": {
        "cardiac": "QTc prolonged"
      }
    },
    {
      "name": "Nemonoxacin",
      "category_raw": "Fluoroquinolone",
      "generation": null,
      "coverage": null,
      "penetration": null,
      "regimens": [
        {
          "route": "IV",
          "indication": null,
          "dosages": null,
          "hd": null,
          "crrt": null
        }
      ],
      "notes": null,
      "toxicities": null
    },
    {
      "name": "Teicoplanin",
      "category_raw": "Glyco/Lipo",
      "generation": null,
      "coverage": {
        "Strep": "v",
        "MSSA": "v",
        "Efc": "v",
        "Efm": "v",
        "MRSA": "++"
      },
      "penetration": null,
      "regimens": [
        {
          "route": "IV",
          "indication": null,
          "dosages": {
            "<5": "360 Q12H x3 doses then 360mg Q3D",
            "5~10": "360 Q12H x3 doses then 360mg Q3D",
            "10~15": "360 Q12H x3 doses then 360mg Q3D",
            "15~20": "360 Q12H x3 doses then 360mg Q3D",
            "20~25": "360 Q12H x3 doses then 360mg Q3D",
            "25~30": "360 Q12H x3 doses then 360mg Q3D",
            "30~40": "360 Q12H x3 doses then 360mg QOD",
            "40~50": "360 Q12H x3 doses then 360mg QOD",
            "50~60": "360 Q12H x3 doses then 360mg QOD",
            "60~80": "360 Q12H x3 doses then 360mg QOD",
            "80~90": "360 Q12H x3 doses then 360mg QD",
            "Normal": "360mg Q12H x3 doses then 360mg QD"
          },
          "hd": "360 Q12H x3 doses then 360mg Q3D",
          "crrt": "360 Q12H x3 doses then 360mg QOD"
        },
        {
          "route": "IV",
          "indication": "感染科建議",
          "dosages": {
            "<5": "600~720 Q12H x3 doses then 480mg Q3D",
            "5~10": "600~720 Q12H x3 doses then 480mg Q3D",
            "10~15": "600~720 Q12H x3 doses then 480mg Q3D",
            "15~20": "600~720 Q12H x3 doses then 480mg Q3D",
            "20~25": "600~720 Q12H x3 doses then 480mg Q3D",
            "25~30": "600~720 Q12H x3 doses then 480mg Q3D",
            "30~40": "600~720 Q12H x3 doses then 480mg QOD",
            "40~50": "600~720 Q12H x3 doses then 480mg QOD",
            "50~60": "600~720 Q12H x3 doses then 480mg QOD",
            "60~80": "600~720 Q12H x3 doses then 480mg QOD",
            "80~90": "600~720 Q12H x3 doses then 480mg QD",
            "Normal": "600~720mg Q12H x3 doses then 480mg QD"
          },
          "hd": "600~720 Q12H x3 doses then 480mg Q3D",
          "crrt": "600~720 Q12H x3 doses then 480mg QOD"
        },
        {
          "route": "IV",
          "indication": "Bone and joint",
          "dosages": {
            "<5": "720 Q12H x3 doses then 720mg Q3D",
            "5~10": "720 Q12H x3 doses then 720mg Q3D",
            "10~15": "720 Q12H x3 doses then 720mg Q3D",
            "15~20": "720 Q12H x3 doses then 720mg Q3D",
            "20~25": "720 Q12H x3 doses then 720mg Q3D",
            "25~30": "720 Q12H x3 doses then 720mg Q3D",
            "30~40": "720 Q12H x3 doses then 720mg QOD",
            "40~50": "720 Q12H x3 doses then 720mg QOD",
            "50~60": "720 Q12H x3 doses then 720mg QOD",
            "60~80": "720 Q12H x3 doses then 720mg QOD",
            "80~90": "720 Q12H x3 doses then 720mg QD",
            "Normal": "720 Q12H x3 doses then 720mg QD"
          },
          "hd": "720 Q12H x3 doses then 720mg Q3D",
          "crrt": "720 Q12H x3 doses then 720mg QOD"
        },
        {
          "route": "IV",
          "indication": "Endocarditis",
          "dosages": {
            "<5": "720 Q12H x3 doses then 720mg Q3D",
            "5~10": "720 Q12H x3 doses then 720mg Q3D",
            "10~15": "720 Q12H x3 doses then 720mg Q3D",
            "15~20": "720 Q12H x3 doses then 720mg Q3D",
            "20~25": "720 Q12H x3 doses then 720mg Q3D",
            "25~30": "720 Q12H x3 doses then 720mg Q3D",
            "30~40": "720 Q12H x3 doses then 720mg QOD",
            "40~50": "720 Q12H x3 doses then 720mg QOD",
            "50~60": "720 Q12H x3 doses then 720mg QOD",
            "60~80": "720 Q12H x3 doses then 720mg QOD",
            "80~90": "720 Q12H x3 doses then 720mg QD",
            "Normal": "720 Q12H x3 doses then 720mg QD"
          },
          "hd": "720 Q12H x3 doses then 720mg Q3D",
          "crrt": "720 Q12H x3 doses then 720mg QOD"
        }
      ],
      "notes": "Not removed by HD; \nTarget trough (Normal): >15 μg/mL; \nTarget trough (Bone and joint): >20 μg/mL; \nTarget trough (Endocarditis): >30 μg/mL",
      "toxicities": null
    },
    {
      "name": "Vancomycin",
      "category_raw": "Glyco/Lipo",
      "generation": null,
      "coverage": {
        "Strep": "v",
        "MSSA": "v",
        "Efc": "v",
        "Efm": "v",
        "MRSA": "++"
      },
      "penetration": {
        "BBB": true,
        "Endo": true
      },
      "regimens": [
        {
          "route": "IV",
          "indication": "AUC",
          "dosages": null,
          "hd": null,
          "crrt": null
        },
        {
          "route": "IV",
          "indication": "Trough",
          "dosages": null,
          "hd": null,
          "crrt": null
        },
        {
          "route": "PO",
          "indication": "C. difficile",
          "dosages": {
            "<5": "125mg Q6H x10 days",
            "5~10": "125mg Q6H x10 days",
            "10~15": "125mg Q6H x10 days",
            "15~20": "125mg Q6H x10 days",
            "20~25": "125mg Q6H x10 days",
            "25~30": "125mg Q6H x10 days",
            "30~40": "125mg Q6H x10 days",
            "40~50": "125mg Q6H x10 days",
            "50~60": "125mg Q6H x10 days",
            "60~80": "125mg Q6H x10 days",
            "80~90": "125mg Q6H x10 days",
            "Normal": "125mg Q6H x10 days"
          },
          "hd": "125mg Q6H x10 days",
          "crrt": "125mg Q6H x10 days"
        }
      ],
      "notes": "肺部穿透力差\nMIC>1mg/L的菌株，劑量易造成毒性; \nPeak：\n靜脈輸注完後 1 個小時抽血; 目前已不建議抽測 peak\nTrough：\n到達穩定狀態的抽血時間大約是四個劑量之後，即第 5 個劑量給藥前 30 分鐘抽血",
      "toxicities": {
        "skin": "red man syndrome"
      }
    },
    {
      "name": "Daptomycin",
      "category_raw": "Glyco/Lipo",
      "generation": null,
      "coverage": {
        "Strep": "v",
        "MSSA": "v",
        "Efc": "v",
        "Efm": "v",
        "MRSA": "++",
        "VRE": "v"
      },
      "penetration": null,
      "regimens": [
        {
          "route": "IV",
          "indication": null,
          "dosages": null,
          "hd": "於洗腎日在洗腎後給予",
          "crrt": null
        },
        {
          "route": "IV",
          "indication": "Bacteremia:VRE",
          "dosages": {
            "Normal": "600~720mg QD (請計算理想體重)"
          },
          "hd": "於洗腎日在洗腎後給予",
          "crrt": null
        }
      ],
      "notes": "會被Pulmonary surfactant分解，故不可用於Pneumonia & 右心 IE\n劑量以 Ideal BW 計算",
      "toxicities": null
    },
    {
      "name": "Linezolid (ZYVOX)",
      "category_raw": "Oxazolid",
      "generation": null,
      "coverage": {
        "Strep": "v",
        "MSSA": "v",
        "Efc": "v",
        "Efm": "v",
        "MRSA": "++",
        "VRE": "v"
      },
      "penetration": null,
      "regimens": [
        {
          "route": "IV/PO",
          "indication": "uncomplicated, e.g. Skin",
          "dosages": {
            "<5": "400mg or 600mg Q12H",
            "5~10": "400mg or 600mg Q12H",
            "10~15": "400mg or 600mg Q12H",
            "15~20": "400mg or 600mg Q12H",
            "20~25": "400mg or 600mg Q12H",
            "25~30": "400mg or 600mg Q12H",
            "30~40": "400mg or 600mg Q12H",
            "40~50": "400mg or 600mg Q12H",
            "50~60": "400mg or 600mg Q12H",
            "60~80": "400mg or 600mg Q12H",
            "80~90": "400mg or 600mg Q12H",
            "Normal": "400mg or 600mg Q12H"
          },
          "hd": "400mg or 600mg Q12H; AD",
          "crrt": "400mg or 600mg Q12H"
        },
        {
          "route": "IV/PO",
          "indication": "complicated, e.g. pneumonia",
          "dosages": {
            "<5": "600mg Q12H",
            "5~10": "600mg Q12H",
            "10~15": "600mg Q12H",
            "15~20": "600mg Q12H",
            "20~25": "600mg Q12H",
            "25~30": "600mg Q12H",
            "30~40": "600mg Q12H",
            "40~50": "600mg Q12H",
            "50~60": "600mg Q12H",
            "60~80": "600mg Q12H",
            "80~90": "600mg Q12H",
            "Normal": "600mg Q12H"
          },
          "hd": "600mg Q12H; AD",
          "crrt": "600mg Q12H"
        }
      ],
      "notes": null,
      "toxicities": {
        "general": "Lactic acidosis",
        "neurologic": "peripheral neuropathy, optic neuropathy",
        "gi": "pancreatitis",
        "hematologic": "Reversible myelosuppression after >2 weeks"
      }
    },
    {
      "name": "Minocycline",
      "category_raw": "Oxazolid",
      "generation": null,
      "coverage": {
        "Steno": "v"
      },
      "penetration": null,
      "regimens": [
        {
          "route": "IV/PO",
          "indication": null,
          "dosages": {
            "<5": "200mg loading, then 100mg Q12H",
            "5~10": "200mg loading, then 100mg Q12H",
            "10~15": "200mg loading, then 100mg Q12H",
            "15~20": "200mg loading, then 100mg Q12H",
            "20~25": "200mg loading, then 100mg Q12H",
            "25~30": "200mg loading, then 100mg Q12H",
            "30~40": "200mg loading, then 100mg Q12H",
            "40~50": "200mg loading, then 100mg Q12H",
            "50~60": "200mg loading, then 100mg Q12H",
            "60~80": "200mg loading, then 100mg Q12H",
            "80~90": "200mg loading, then 100mg Q12H",
            "Normal": "200mg loading, then 100mg Q12H"
          },
          "hd": "200mg loading, then 100mg Q12H",
          "crrt": "200mg loading, then 100mg Q12H"
        },
        {
          "route": "IV_PO",
          "indication": "Stenotrophomonas m.",
          "dosages": {
            "<5": "200mg Q12H",
            "5~10": "200mg Q12H",
            "10~15": "200mg Q12H",
            "15~20": "200mg Q12H",
            "20~25": "200mg Q12H",
            "25~30": "200mg Q12H",
            "30~40": "200mg Q12H",
            "40~50": "200mg Q12H",
            "50~60": "200mg Q12H",
            "60~80": "200mg Q12H",
            "80~90": "200mg Q12H",
            "Normal": "200mg Q12H"
          },
          "hd": "200mg Q12H",
          "crrt": "200mg Q12H"
        }
      ],
      "notes": "Infuse IV doses > 60 minutes;\n前驅物含Mg!!! 腎功能不佳者請監測",
      "toxicities": {
        "gi": "pancreatitis"
      }
    },
    {
      "name": "Tigecycline",
      "category_raw": "Tetracyclines",
      "generation": null,
      "coverage": {
        "Strep": "v",
        "MSSA": "v",
        "Efc": "v",
        "Efm": "v",
        "Anae": "+",
        "Atyp": "+",
        "MRSA": "++",
        "ESBL": "v",
        "VRE": "v",
        "CRKP": "v"
      },
      "penetration": null,
      "regimens": [
        {
          "route": "IV",
          "indication": null,
          "dosages": {
            "<5": "100mg, then 50mg Q12h",
            "5~10": "100mg, then 50mg Q12h",
            "10~15": "100mg, then 50mg Q12h",
            "15~20": "100mg, then 50mg Q12h",
            "20~25": "100mg, then 50mg Q12h",
            "25~30": "100mg, then 50mg Q12h",
            "30~40": "100mg, then 50mg Q12h",
            "40~50": "100mg, then 50mg Q12h",
            "50~60": "100mg, then 50mg Q12h",
            "60~80": "100mg, then 50mg Q12h",
            "80~90": "100mg, then 50mg Q12h",
            "Normal": "100mg, then 50mg Q12h"
          },
          "hd": "100mg, then 50mg Q12h",
          "crrt": "100mg, then 50mg Q12h"
        },
        {
          "route": "IV",
          "indication": "Child-Pugh C",
          "dosages": {
            "<5": "100mg, then 25mg Q12h",
            "5~10": "100mg, then 25mg Q12h",
            "10~15": "100mg, then 25mg Q12h",
            "15~20": "100mg, then 25mg Q12h",
            "20~25": "100mg, then 25mg Q12h",
            "25~30": "100mg, then 25mg Q12h",
            "30~40": "100mg, then 25mg Q12h",
            "40~50": "100mg, then 25mg Q12h",
            "50~60": "100mg, then 25mg Q12h",
            "60~80": "100mg, then 25mg Q12h",
            "80~90": "100mg, then 25mg Q12h",
            "Normal": "100mg, then 25mg Q12h"
          },
          "hd": "100mg, then 25mg Q12h",
          "crrt": "100mg, then 25mg Q12h"
        }
      ],
      "notes": "先天抗藥性: P. aeruginosa, Providencia, Proteus, Morganella\n在血液及尿液中濃度低。單用會造成mortality 上升。\nChild-Pugh Class C: 100 mg IV, then 25 mg IV q12h",
      "toxicities": {
        "neurologic": "pseudotumor cerebri",
        "gi": "N/V, pancreatitis",
        "skin": "photosensitivity"
      }
    },
    {
      "name": "Erythromycin",
      "category_raw": "Macrolides",
      "generation": null,
      "coverage": null,
      "penetration": null,
      "regimens": [
        {
          "route": "IV",
          "indication": null,
          "dosages": null,
          "hd": null,
          "crrt": null
        }
      ],
      "notes": "注意 QTc prolonged",
      "toxicities": {
        "cardiac": "QTc prolonged"
      }
    },
    {
      "name": "Azithromycin",
      "category_raw": "Macrolides",
      "generation": null,
      "coverage": {
        "Atyp": "++"
      },
      "penetration": null,
      "regimens": [
        {
          "route": "IV",
          "indication": null,
          "dosages": null,
          "hd": null,
          "crrt": null
        }
      ],
      "notes": "注意 QTc prolonged",
      "toxicities": {
        "cardiac": "QTc prolonged"
      }
    },
    {
      "name": "Clindamycin",
      "category_raw": "Lincosamide",
      "generation": null,
      "coverage": {
        "MSSA": "v",
        "Anae": "+"
      },
      "penetration": null,
      "regimens": [
        {
          "route": "IV",
          "indication": null,
          "dosages": null,
          "hd": null,
          "crrt": null
        }
      ],
      "notes": null,
      "toxicities": null
    },
    {
      "name": "Colistin (polymyxin E)",
      "category_raw": "Polymyxins",
      "generation": null,
      "coverage": {
        "PsA": "+",
        "MRSA": "+",
        "MDRAB": "v"
      },
      "penetration": null,
      "regimens": [
        {
          "route": "INHL",
          "indication": "Decolonization",
          "dosages": {
            "<5": "2M IU Q12H",
            "5~10": "2M IU Q12H",
            "10~15": "2M IU Q12H",
            "15~20": "2M IU Q12H",
            "20~25": "2M IU Q12H",
            "25~30": "2M IU Q12H",
            "30~40": "2M IU Q12H",
            "40~50": "2M IU Q12H",
            "50~60": "2M IU Q12H",
            "60~80": "2M IU Q12H",
            "80~90": "2M IU Q12H",
            "Normal": "2M IU Q12H"
          },
          "hd": "2M IU Q12H",
          "crrt": "2M IU Q12H"
        },
        {
          "route": "INHL",
          "indication": "Treatment",
          "dosages": {
            "<5": "2M IU Q8H",
            "5~10": "2M IU Q8H",
            "10~15": "2M IU Q8H",
            "15~20": "2M IU Q8H",
            "20~25": "2M IU Q8H",
            "25~30": "2M IU Q8H",
            "30~40": "2M IU Q8H",
            "40~50": "2M IU Q8H",
            "50~60": "2M IU Q8H",
            "60~80": "2M IU Q8H",
            "80~90": "2M IU Q8H",
            "Normal": "2M IU Q8H"
          },
          "hd": "2M IU Q8H",
          "crrt": "2M IU Q8H"
        },
        {
          "route": "IV",
          "indication": null,
          "dosages": null,
          "hd": null,
          "crrt": null
        }
      ],
      "notes": "先天抗藥性: Serratia marcescens, Proteus mirabilis, Burkholderia spp., Stenotrophomonas maltophilia, Elizabethkingia spp., Morganella spp., Providencia spp., Moraxella catarrhalis\n1 vial = 2 百萬單位= CoIistimethate sodium (CMS) 160mg = CoIistin 66.8mg\n1 mg CBA (colistin base activity) = 30,000 IU CMS (colistimethate, prodrug) = 2.4 mg CMS",
      "toxicities": null
    },
    {
      "name": "Bobimixyn (Polymyxin B)",
      "category_raw": "Polymyxins",
      "generation": null,
      "coverage": null,
      "penetration": null,
      "regimens": [
        {
          "route": "IV",
          "indication": null,
          "dosages": null,
          "hd": null,
          "crrt": null
        }
      ],
      "notes": "請勿用於 UTI; 請勿使用 INHL\n先天抗藥性: Serratia marcescens, Proteus mirabilis, Burkholderia spp., Stenotrophomonas maltophilia, Elizabethkingia spp., Morganella spp., Providencia spp., Moraxella catarrhalis",
      "toxicities": null
    },
    {
      "name": "Amikacin",
      "category_raw": "Aminoglycosides",
      "generation": null,
      "coverage": null,
      "penetration": null,
      "regimens": [
        {
          "route": "IV",
          "indication": "Loading",
          "dosages": {
            "<5": "900mg ST",
            "5~10": "900mg ST",
            "10~15": "900mg ST",
            "15~20": "900mg ST",
            "20~25": "900mg ST",
            "25~30": "900mg ST",
            "30~40": "900mg ST",
            "40~50": "900mg ST",
            "50~60": "900mg ST",
            "60~80": "900mg ST",
            "80~90": "900mg ST",
            "Normal": "900mg ST"
          },
          "hd": "900mg ST",
          "crrt": null
        },
        {
          "route": "IV",
          "indication": "一天一次",
          "dosages": {
            "<5": "180mg Q3D and AD",
            "5~10": "180mg Q3D and AD",
            "10~15": "240mg QOD",
            "15~20": "240mg QOD",
            "20~25": "450mg QOD",
            "25~30": "450mg QOD",
            "30~40": "240mg QD",
            "40~50": "450mg QD",
            "50~60": "450mg QD",
            "60~80": "720mg QD",
            "80~90": "720mg QD",
            "Normal": "900mg QD"
          },
          "hd": "180mg Q3D and AD",
          "crrt": "No data"
        },
        {
          "route": "IV",
          "indication": "一天數次",
          "dosages": {
            "<5": "450mg QOD",
            "5~10": "450mg QOD",
            "10~15": "450mg QD",
            "15~20": "450mg QD",
            "20~25": "450mg QD",
            "25~30": "450mg QD",
            "30~40": "450mg QD",
            "40~50": "450mg QD",
            "50~60": "450mg Q12H",
            "60~80": "450mg Q12H",
            "80~90": "450mg Q12H",
            "Normal": "450mg Q12H"
          },
          "hd": "450mg QOD + extra 225mg AD",
          "crrt": "450mg QD"
        },
        {
          "route": "INHL",
          "indication": null,
          "dosages": {
            "<5": "400~500mg Q12H",
            "5~10": "400~500mg Q12H",
            "10~15": "400~500mg Q12H",
            "15~20": "400~500mg Q12H",
            "20~25": "400~500mg Q12H",
            "25~30": "400~500mg Q12H",
            "30~40": "400~500mg Q12H",
            "40~50": "400~500mg Q12H",
            "50~60": "400~500mg Q12H",
            "60~80": "400~500mg Q12H",
            "80~90": "400~500mg Q12H",
            "Normal": "400~500mg Q12H"
          },
          "hd": "400~500mg Q12H",
          "crrt": "400~500mg Q12H"
        }
      ],
      "notes": "IV form 肺部穿透力差\nRun >1 hr; \n一天一次: Target Trough <1 μg/mL; Target peak 56-64 μg/mL; \n一天數次: Target Peak 15–30 μg/mL, Trough 5–10 μg/mL",
      "toxicities": null
    },
    {
      "name": "Baktar (TMP/SMX)(Dose base on TMP)",
      "category_raw": "OTHER",
      "generation": null,
      "coverage": {
        "MSSA": "v",
        "Steno": "v",
        "MRSA": "+"
      },
      "penetration": {
        "Pros": true
      },
      "regimens": [
        {
          "route": "IV/PO",
          "indication": null,
          "dosages": {
            "<5": "不建議, 若需使用則 300~600mg QD",
            "5~10": "不建議, 若需使用則 300~600mg QD",
            "10~15": "150~300mg/day divided Q12H",
            "15~20": "150~300mg/day divided Q12H",
            "20~25": "150~300mg/day divided Q12H",
            "25~30": "150~300mg/day divided Q12H",
            "30~40": "300~1200mg/day divided Q6~Q12H",
            "40~50": "300~1200mg/day divided Q6~Q12H",
            "50~60": "300~1200mg/day divided Q6~Q12H",
            "60~80": "300~1200mg/day divided Q6~Q12H",
            "80~90": "300~1200mg/day divided Q6~Q12H",
            "Normal": "300~1200mg/day divided Q6~Q12H"
          },
          "hd": "不建議, 若需使用則 300~600mg QD; AD",
          "crrt": "300mg Q8H"
        },
        {
          "route": "IV_PO",
          "indication": "Stenotrophomonas m.",
          "dosages": {
            "30~40": "480~720mg/day divided Q8~Q12H",
            "40~50": "480~720mg/day divided Q8~Q12H",
            "50~60": "480~720mg/day divided Q8~Q12H",
            "60~80": "480~720mg/day divided Q8~Q12H",
            "80~90": "480~720mg/day divided Q8~Q12H",
            "Normal": "480~720mg/day divided Q8~Q12H"
          },
          "hd": null,
          "crrt": null
        }
      ],
      "notes": "Dose based on TMP; 每 5ml in 75ml D5W (in N/S 可能會結晶)\nnot to treat enterococcal cystitis, streptococcal pharyngitis despite active in vitro\n注意高血鉀，腎功能差、併用 Spirolactone、ACEI、ARB 須謹慎",
      "toxicities": null
    },
    {
      "name": "Metronidazole",
      "category_raw": "OTHER",
      "generation": null,
      "coverage": {
        "Anae": "++"
      },
      "penetration": {
        "BBB": true
      },
      "regimens": [
        {
          "route": "IV/PO",
          "indication": null,
          "dosages": {
            "<5": "450mg Q12H",
            "5~10": "450mg Q12H",
            "10~15": "450mg Q6H",
            "15~20": "450mg Q6H",
            "20~25": "450mg Q6H",
            "25~30": "450mg Q6H",
            "30~40": "450mg Q6H",
            "40~50": "450mg Q6H",
            "50~60": "450mg Q6H",
            "60~80": "450mg Q6H",
            "80~90": "450mg Q6H",
            "Normal": "450mg Q6H"
          },
          "hd": "450mg Q12H; AD",
          "crrt": "450mg Q6H"
        }
      ],
      "notes": "50% dosage reduction recommended for severe (Child-Pugh Class C) impairment",
      "toxicities": {
        "neurologic": "Aseptic meningitis, encephalopathy, seizures",
        "gi": "acute pancreatitis"
      }
    },
    {
      "name": "Rifampin",
      "category_raw": "OTHER",
      "generation": null,
      "coverage": {
        "Efc": "v",
        "Efm": "v"
      },
      "penetration": {
        "BBB": true
      },
      "regimens": [
        {
          "route": "IV",
          "indication": null,
          "dosages": null,
          "hd": null,
          "crrt": null
        }
      ],
      "notes": null,
      "toxicities": null
    },
    {
      "name": "Fosfomycin",
      "category_raw": "OTHER",
      "generation": null,
      "coverage": {
        "Strep": "v",
        "MSSA": "v",
        "Efc": "v",
        "Efm": "v",
        "ESBL": "v"
      },
      "penetration": null,
      "regimens": [
        {
          "route": "IV",
          "indication": null,
          "dosages": null,
          "hd": null,
          "crrt": null
        }
      ],
      "notes": "須注意Hypernatremia; 經驗性使用 1g Q12H",
      "toxicities": null
    },
    {
      "name": "Fluconazole",
      "category_raw": "Antifungal",
      "generation": null,
      "coverage": null,
      "penetration": null,
      "regimens": [
        {
          "route": "IV/PO",
          "indication": null,
          "dosages": {
            "<5": "50~200mg QD",
            "5~10": "50~200mg QD",
            "10~15": "50~200mg QD",
            "15~20": "50~200mg QD",
            "20~25": "50~200mg QD",
            "25~30": "50~200mg QD",
            "30~40": "50~200mg QD",
            "40~50": "50~200mg QD",
            "50~60": "100~400mg QD",
            "60~80": "100~400mg QD",
            "80~90": "100~400mg QD",
            "Normal": "100~400mg QD"
          },
          "hd": "50-200 mg q24h (非洗腎日), 100-400 mg (full dose) AD (洗腎日)",
          "crrt": null
        }
      ],
      "notes": "注意 QTc prolonged",
      "toxicities": {
        "cardiac": "QTc prolonged"
      }
    },
    {
      "name": "Voriconazole",
      "category_raw": "Antifungal",
      "generation": null,
      "coverage": {
        "Glabrata": "v"
      },
      "penetration": null,
      "regimens": [
        {
          "route": "PO",
          "indication": null,
          "dosages": {
            "<5": "200 mg Q12H",
            "5~10": "200 mg Q12H",
            "10~15": "200 mg Q12H",
            "15~20": "200 mg Q12H",
            "20~25": "200 mg Q12H",
            "25~30": "200 mg Q12H",
            "30~40": "200 mg Q12H",
            "40~50": "200 mg Q12H",
            "50~60": "200 mg Q12H",
            "60~80": "200 mg Q12H",
            "80~90": "200 mg Q12H",
            "Normal": "200 mg Q12H"
          },
          "hd": "200 mg Q12H",
          "crrt": "200 mg Q12H"
        },
        {
          "route": "IV",
          "indication": null,
          "dosages": {
            "<5": "Avoid",
            "5~10": "Avoid",
            "10~15": "Avoid",
            "15~20": "Avoid",
            "20~25": "Avoid",
            "25~30": "Avoid",
            "30~40": "Avoid",
            "40~50": "Avoid",
            "50~60": "360mg Q12H ST*2, then 180~240mg Q12H",
            "60~80": "360mg Q12H ST*2, then 180~240mg Q12H",
            "80~90": "360mg Q12H ST*2, then 180~240mg Q12H",
            "Normal": "360mg Q12H ST*2, then 180~240mg Q12H"
          },
          "hd": "360mg Q12H ST*2, then 180~240mg Q12H",
          "crrt": "360mg Q12H ST*2, then 180~240mg Q12H"
        }
      ],
      "notes": "注意 QTc prolonged\n應飯前 2hrs 服用，因為食物會影響吸收\n[熱病]CrCl <50 mL/min.的病人應以口服給予，避免IV，因其IV賦形劑 SBECD (sulfobutylether-β cyclodextrin) 會於體內累積，進而可能導致 Hallucinations, hypoglycemia, electrolyte disturbance and pneumonitis",
      "toxicities": {
        "cardiac": "QTc prolonged"
      }
    },
    {
      "name": "Flucytosine",
      "category_raw": "Antifungal",
      "generation": null,
      "coverage": {
        "Glabrata": "v"
      },
      "penetration": null,
      "regimens": [
        {
          "route": "PO",
          "indication": null,
          "dosages": null,
          "hd": null,
          "crrt": null
        }
      ],
      "notes": null,
      "toxicities": null
    },
    {
      "name": "Anidulafungin = ERAXIS",
      "category_raw": "Antifungal",
      "generation": null,
      "coverage": {
        "Glabrata": "v"
      },
      "penetration": null,
      "regimens": [
        {
          "route": "IV",
          "indication": "Candidemia",
          "dosages": {
            "<5": "200mg ST, then 100mg QD",
            "5~10": "200mg ST, then 100mg QD",
            "10~15": "200mg ST, then 100mg QD",
            "15~20": "200mg ST, then 100mg QD",
            "20~25": "200mg ST, then 100mg QD",
            "25~30": "200mg ST, then 100mg QD",
            "30~40": "200mg ST, then 100mg QD",
            "40~50": "200mg ST, then 100mg QD",
            "50~60": "200mg ST, then 100mg QD",
            "60~80": "200mg ST, then 100mg QD",
            "80~90": "200mg ST, then 100mg QD",
            "Normal": "200mg ST, then 100mg QD"
          },
          "hd": "200mg ST, then 100mg QD",
          "crrt": "200mg ST, then 100mg QD"
        },
        {
          "route": "IV",
          "indication": "Esophageal Candida",
          "dosages": {
            "<5": "100mg ST, then 50mg QD",
            "5~10": "100mg ST, then 50mg QD",
            "10~15": "100mg ST, then 50mg QD",
            "15~20": "100mg ST, then 50mg QD",
            "20~25": "100mg ST, then 50mg QD",
            "25~30": "100mg ST, then 50mg QD",
            "30~40": "100mg ST, then 50mg QD",
            "40~50": "100mg ST, then 50mg QD",
            "50~60": "100mg ST, then 50mg QD",
            "60~80": "100mg ST, then 50mg QD",
            "80~90": "100mg ST, then 50mg QD",
            "Normal": "100mg ST, then 50mg QD"
          },
          "hd": "100mg ST, then 50mg QD",
          "crrt": "100mg ST, then 50mg QD"
        }
      ],
      "notes": "不能治療 UTI",
      "toxicities": null
    },
    {
      "name": "Isavuconazole",
      "category_raw": "Antifungal",
      "generation": null,
      "coverage": null,
      "penetration": null,
      "regimens": [
        {
          "route": "IV",
          "indication": null,
          "dosages": null,
          "hd": null,
          "crrt": null
        }
      ],
      "notes": "一支cresemba加入5 mL注射用水，輕輕搖晃，使粉末完全溶解, 之後稀釋,  之後再用normal \r\nsaline稀釋成20cc 從NG管灌, 灌完再沖10cc的水",
      "toxicities": null
    },
    {
      "name": "Amphotericin B",
      "category_raw": "Antifungal",
      "generation": null,
      "coverage": null,
      "penetration": null,
      "regimens": [
        {
          "route": "IV",
          "indication": null,
          "dosages": null,
          "hd": null,
          "crrt": null
        }
      ],
      "notes": null,
      "toxicities": null
    },
    {
      "name": "Acyclovir",
      "category_raw": "Antiviral",
      "generation": null,
      "coverage": null,
      "penetration": null,
      "regimens": [
        {
          "route": "PO",
          "indication": "HSV",
          "dosages": {
            "<5": "800mg Q12H",
            "5~10": "800mg Q12H",
            "10~15": "800mg Q8H",
            "15~20": "800mg Q8H",
            "20~25": "800mg Q8H",
            "25~30": "800mg PID",
            "30~40": "800mg PID",
            "40~50": "800mg PID",
            "50~60": "800mg PID",
            "60~80": "800mg PID",
            "80~90": "800mg PID",
            "Normal": "400mg Q8H"
          },
          "hd": "800mg Q12H; extra dose AD",
          "crrt": "800mg Q12H"
        },
        {
          "route": "PO",
          "indication": "VZV",
          "dosages": {
            "<5": "800mg Q12H",
            "5~10": "800mg Q12H",
            "10~15": "800mg Q8H",
            "15~20": "800mg Q8H",
            "20~25": "800mg Q8H",
            "25~30": "800mg PID",
            "30~40": "800mg PID",
            "40~50": "800mg PID",
            "50~60": "800mg PID",
            "60~80": "800mg PID",
            "80~90": "800mg PID",
            "Normal": "800mg PID"
          },
          "hd": "800mg Q12H; extra dose AD",
          "crrt": "800mg Q12H"
        },
        {
          "route": "IV",
          "indication": null,
          "dosages": {
            "<5": "150~375mg QD",
            "5~10": "150~375mg QD",
            "10~15": "300~750mg Q12H~QD",
            "15~20": "300~750mg Q12H~QD",
            "20~25": "300~750mg Q12H~QD",
            "25~30": "300~750mg Q12H~QD",
            "30~40": "300~750mg Q12H~QD",
            "40~50": "300~750mg Q12H~QD",
            "50~60": "300~750mg Q8H",
            "60~80": "300~750mg Q8H",
            "80~90": "300~750mg Q8H",
            "Normal": "300~750mg Q8H"
          },
          "hd": "150~375mg QD; AD",
          "crrt": "150~375mg QD"
        }
      ],
      "notes": "Herpes simplex virus\nVaricella-zoster virus\n(not CMV)\n腦炎、腦膜炎10/kg\npost-hydration + pre-hydration",
      "toxicities": {
        "general": "vertigo",
        "neurologic": "hallucinations, death delusions, and involuntary movements",
        "musculoskeletal": "arthralgia, muscle cramps",
        "gi": "diarrhea",
        "obgyn": "menstrual abnormalities",
        "hematologic": "lymphadenopathy"
      }
    },
    {
      "name": "Ganciclovir",
      "category_raw": "Antiviral",
      "generation": null,
      "coverage": null,
      "penetration": null,
      "regimens": [
        {
          "route": "PO",
          "indication": null,
          "dosages": null,
          "hd": null,
          "crrt": null
        },
        {
          "route": "IV",
          "indication": "induction",
          "dosages": null,
          "hd": null,
          "crrt": null
        },
        {
          "route": "IV",
          "indication": "maintenance",
          "dosages": null,
          "hd": null,
          "crrt": null
        }
      ],
      "notes": null,
      "toxicities": null
    },
    {
      "name": "Peramivir = Rapiacta",
      "category_raw": "Antiviral",
      "generation": null,
      "coverage": null,
      "penetration": null,
      "regimens": [
        {
          "route": "IV",
          "indication": null,
          "dosages": null,
          "hd": null,
          "crrt": null
        }
      ],
      "notes": null,
      "toxicities": null
    }
  ]
}